Sign in

Colorectal cancer

Current status: Treatable, not yet curable

A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.

Read more about colorectal cancer

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Where research stands todayUpdated 16 Nov 2026

Trial-stage treatments and research studies you can join

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsPoland, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 3Taking people
    Tests calderasib with chemotherapy and cetuximab in colorectal cancer

    Tests calderasib with chemotherapy in adults with KRAS G12C colorectal cancer.

    Gliwice, PolandAlso Koszalin, Poznan, Rzeszów, WarsawAge 18+
  2. Trial-stage treatmentPhase 1Taking people
    Testing Targeted Treatments in Metastatic Colorectal Cancer by Tumor Marker

    Tests targeted drugs and immunotherapy in adults with colorectal cancer that has spread.

    Gdansk, PolandAlso Poznan, WarsawAge 18+
  3. Trial-stage treatmentPhase 3Taking people
    Tests ivonescimab with chemotherapy against bevacizumab for colorectal cancer

    Compares ivonescimab plus chemotherapy with bevacizumab plus chemotherapy in adults with metastatic colorectal cancer.

    Gdansk, PolandAlso Olsztyn, Otwock, Rzeszów, WarsawAge 18+
  4. Trial-stage treatmentPhase 3Taking people
    New treatments tested in adults with colorectal cancer that has spread after earlier treatment

    Compares precemtabart tocentecan with or without bevacizumab against standard treatment in colorectal cancer.

    Gdansk, PolandAlso LodzAge 18+
  5. Trial-stage treatmentPhase 3Taking people
    Tests amivantamab with chemotherapy against cetuximab for left-sided colorectal cancer

    Tests amivantamab and chemotherapy against cetuximab in adults with left-sided colorectal cancer.

    Bialystok, PolandAlso Brzozów, Gdansk, Gliwice, Lodz, Olsztyn, WarsawAge 18+
  6. Trial-stage treatmentPhase 3Taking people
    Tests amivantamab with chemotherapy in colorectal cancer that returned or spread

    Compares amivantamab plus FOLFIRI against standard treatment in adults with colorectal cancer.

    Bialystok, PolandAlso Brzozów, Gdansk, Lodz, Olsztyn, WarsawAge 18+
  7. Trial-stage treatmentPhase 1/2Taking people
    EIK1005 alone or with pembrolizumab for advanced solid tumors

    Tests EIK1005, alone and with pembrolizumab, in adults with advanced solid tumors.

    Krakow, PolandAlso Lódz, SzczecinAge 18+
  8. Trial-stage treatmentPhase 3Soon in Poland
    Tests a new drug added to chemotherapy for advanced bowel cancer

    Tests INCA33890 with chemotherapy and bevacizumab in adults with advanced colorectal cancer.

    Warsaw, PolandAge 18+
  9. Trial-stage treatmentPhase 1/2Taking people
    Tests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors

    Tests ifinatamab deruxtecan in adults with solid tumors that returned or spread.

    Lodz, PolandAlso Rzeszów, SkorzewoAge 18+
  10. Trial-stage treatmentPhase 2/3Taking people
    Tests pumitamig with chemotherapy against bevacizumab in colorectal cancer

    Compares pumitamig plus chemotherapy with bevacizumab plus chemotherapy in untreated colorectal cancer.

    Brzozów, PolandAlso Gdansk, Gliwice, Jelenia Góra, Koszalin, WarsawAge 18+
  11. Trial-stage treatmentPhase 2Soon in Poland
    Tests VVD-133214 with pembrolizumab in advanced colorectal cancer

    Tests VVD-133214 plus pembrolizumab in adults with advanced colorectal cancer with MSI or dMMR.

    Bialystok, PolandAlso Krakow, Lodz, Opole, Otwock, Przemyśl, Siedlce, Skórzewo, Warsaw, …Age 18+
  12. Trial-stage treatmentPhase 1/2Taking people
    Tests risvutatug rezetecan in advanced gastrointestinal cancers after prior treatment

    Tests a new medicine, risvutatug rezetecan, in adults with advanced gastrointestinal cancer.

    Brzozów, PolandAlso Koszalin, WarsawAge 18+
  13. Trial-stage treatmentPhase 3Taking people
    Tests a new medicine with chemotherapy for colon or rectal cancer that has spread

    Compares new medicine PF-08634404 with chemotherapy against bevacizumab with chemotherapy in adults with colorectal cancer.

    Katowice, PolandAlso Koszalin, PoznanAge 18+
  14. Trial-stage treatmentPhase 1Taking people
    Tests zanzalintinib, alone or with immunotherapy, in adults with advanced solid tumors

    Tests zanzalintinib with other drugs in adults with advanced solid tumors.

    Bydgoszcz, PolandAlso Gdansk, Otwock, Poznan, WroclawAge 18+
  15. Trial-stage treatmentPhase 2Taking people
    Tests datopotamab deruxtecan alone or combined with other drugs in advanced solid tumours

    Tests datopotamab deruxtecan, alone or combined, in adults with advanced solid tumours.

    Gliwice, PolandAlso WarsawAge 18 to 130
  16. Trial-stage treatmentPhase 3Taking people
    Tests sotorasib with panitumumab and FOLFIRI in colorectal cancer

    Compares sotorasib combination treatment with FOLFIRI in adults with KRAS-mutated colorectal cancer.

    Gdynia, PolandAlso Kielce, Lodz, Opole, Poznan, WarsawAge 18+
  17. Trial-stage treatmentPhase 1Taking people
    First-in-human study of OATD-02 in advanced solid tumours

    Tests the new drug OATD-02 in adults with advanced colorectal, ovarian, pancreatic or kidney cancer.

    Bydgoszcz, PolandAlso Otwock, WarsawAge 18+
  18. Trial-stage treatmentPhase 3Taking people
    Tests tucatinib with other drugs in HER2-positive colorectal cancer

    Tests tucatinib with trastuzumab and chemotherapy against standard treatment in adults with HER2-positive colorectal cancer.

    Gdansk, PolandAlso Konin, Rzeszów, WarsawAge 18+
  19. Trial-stage treatmentTaking people
    Close Follow-Up Versus Chemoradiotherapy After Removal of Early Rectal Cancer

    Compares close follow-up with chemoradiotherapy in adults after early rectal cancer removal.

    Gdansk, PolandAlso WarsawAge 18+
  20. Trial-stage treatmentPhase 1/2
    Tests repotrectinib in advanced solid tumors with certain gene rearrangements

    Tests the oral drug repotrectinib in people with advanced solid tumors and gene changes.

    Gdansk, PolandAlso WarsawAge 12+

Trials that have ended are not listed here, because nobody can join them. Stopped and finished Colorectal cancer trials (research view)

Where treatment stands

In the EU, fruquintinib got its first authorisation in June 2024.

Approved: 26

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 64

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 5

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 2

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Words used here

Placebo: a dummy treatment without the medicine, used for comparison.

Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.

Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 473 other open phase 2 trials are not listed.

Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for colorectal cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.

Not medical advice. Talk to your doctor before you change any treatment.

The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.

Support organisations

Patient organisations and helplines in Poland, for you and your family.

Colorectal cancer organisations in Poland

  • Fundacja EuropaColon Polska

    Digestive cancer foundation, mainly colorectal but also pancreatic and other digestive cancers: guides, app, nutrition and psycho-oncology resources, trial links. DiCE and WPCC member.

  • Polska Liga Walki z Rakiem

    Polish cancer league (ECL member) building cooperation between health care, education, science and social policy to fight cancer and support patients.

General support in Poland

  • Centrum Wsparcia dla osób dorosłych w kryzysie psychicznym

    Free 24/7 support line (800 70 2222) and chat for adults in psychological crisis in Poland, funded by the Ministry of Health.

  • pacjent.gov.pl

    Patient portal of the Polish Ministry of Health and National Health Fund with reliable, verified information on health and the care system.

  • Rzecznik Praw Pacjenta

    Poland's central government Patient Ombudsman protecting patient rights, with a free patient helpline (800 190 590).

International organisations

Patient organisation umbrella bodies

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

26 medicines are approved for colorectal cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 11 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

“Cures” others already fact-checked

See all 5

About colorectal cancer

Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER

A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.

What is it?

Bowel cancer, also called colorectal cancer, is cancer anywhere in the large bowel: the colon or the rectum. The large bowel takes water from food and gets rid of waste. It is one of the most common cancers.

The risk grows with age, and you are more likely to get it if you are over 50. It is most often found in people aged 65 to 74. It is more likely if a close relative has had bowel cancer, or if you have an inherited condition such as Lynch syndrome or familial adenomatous polyposis (FAP). Crohn's disease or ulcerative colitis, bowel polyps (small growths), smoking and being overweight also raise the risk. Eating more fruit and vegetables, less red and processed meat, being active and drinking less alcohol can lower it.

The first signs

Bowel cancer may not cause signs at first.

  • changes in their poo that are not usual for them, such as softer poo, diarrhoea or constipation;
  • needing to poo more or less often than usual;
  • blood in their poo, which can look red or black, or bleeding from the bottom;
  • often feeling they need to poo, even just after going to the toilet;
  • tummy pain, a lump in the tummy or bloating;
  • losing weight without trying.

Feeling very tired or short of breath can be a sign of anaemia, which can be caused by bowel cancer. These signs often have other causes.

How doctors find out

If your family doctor thinks you could have bowel cancer, they send you to a specialist. The main test is a colonoscopy: a thin, bendy tube with a camera looks inside your bowel. It may be uncomfortable but should not hurt, and you are offered a sedative and painkillers. A small piece of the bowel lining (a biopsy) can be taken for testing. Stool tests that look for hidden blood are also used.

If it is cancer, CT, MRI or PET scans, blood tests and gene tests show how far it has spread and whether certain gene changes are involved. This helps your team choose the treatment. A specialist nurse is your main contact during and after treatment.

Current treatment

Surgery, often with chemotherapy or radiotherapy

Will it get worse?

It depends on how big the cancer is, whether it has spread, and your general health. About 23 in 100 bowel cancers have spread to other parts of the body when they are found. The outlook also depends on whether surgery can remove all of the tumour and whether the bowel is blocked.

Advanced bowel cancer can be hard to treat. Then treatment aims to slow the cancer, ease symptoms and help you live longer, and a palliative care team helps with symptoms and comfort. After treatment you have check-ups and tests. A blood test called CEA may be done to see whether the cancer has come back.

Medicines: what helps, and what to watch for

Chemotherapy is medicine that kills cancer cells. You may have it before surgery to shrink the cancer, after surgery to lower the chance of it coming back, instead of surgery, or when the cancer has spread. For advanced bowel cancer, targeted medicines can stop or slow its growth, and immunotherapy helps your immune system attack it. Biomarker tests can help predict how you will respond to certain targeted medicines.

Good to know:

  • Most people get some side effects of chemotherapy, but not all of them. Common ones are tiredness, feeling sick, a sore mouth, diarrhoea or constipation, hair loss that is usually temporary, and numbness or tingling in the hands or feet;
  • Your team explains the benefits and side effects of each treatment and helps you manage them.

Exercise and diet after surgery

If you have a stoma after surgery (see below), start with gentle activity, such as a short walk, when you feel ready. Once your bowel has settled, go back to your usual, balanced food.

Surgery and radiotherapy

Surgery is the most common treatment at every stage of colon cancer. The surgeon removes the cancer and some of the bowel around it. If the cancer is in a polyp, the polyp is often removed during a colonoscopy. The surgeon may then join the two healthy ends of the bowel back together. If the ends cannot be joined, a stoma (an opening on the outside of the body for waste to pass through) is made, and a bag collects the waste. It can be temporary or permanent.

Radiotherapy uses beams of radiation to kill cancer cells. It is used for cancer in the rectum and for cancer that has spread. If the cancer has spread to the liver, those parts may be removed by surgery. If you cannot have surgery, they may be destroyed with heat or by freezing.

Is there a cure?

Your outlook and treatment depend on the stage of the cancer. Bowel cancer found early, for example through screening, may be easier to treat. Advanced bowel cancer that has spread may be hard to treat and not possible to cure. New treatments are being tested in clinical trials.

See the 2,191 trials you can join

Median survival

About 29 to 30 months with first-line treatment, once it has spread

Measured in: Previously untreated metastatic colorectal cancer with KRAS wild-type tumours: the CALGB/SWOG 80405 trial (2,334 patients)

The figures behind it

NCI PDQ (health professional, colon), CALGB/SWOG 80405 (2,334 previously untreated patients with KRAS wild-type metastatic colorectal cancer): median overall survival 29.04 months with chemotherapy plus bevacizumab and 29.93 months with chemotherapy plus cetuximab; the difference was not statistically significant.